ArticleFrontiers in immunology2024

Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors.

Jingjing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.